---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-25-028530"
form_type: "8-K"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2025-09-08T23:59:59+00:00"
generated_at: "2026-05-28T19:46:10.165598+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Cassava Sciences files 8-K with corporate presentation; no specific facts extracted

## Summary
- Company furnished a corporate presentation dated September 2025 as Exhibit 99.1.
- Presentation is available on the Investors section of CassavaSciences.com.
- No financial results, guidance, or business updates are disclosed in the filing.

## SEC filing metadata
- accession: 0001437749-25-028530
- form_type: 8-K
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2025-09-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000143774925028530/0001437749-25-028530-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000143774925028530/sava20250904_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-25-028530
- JSON: https://secwatch.observer/filing/0001437749-25-028530.json
- Plain text: https://secwatch.observer/filing/0001437749-25-028530.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.